Compositions and methods of treating disease with FGFR fusion proteins

Details for Australian Patent Application No. 2011244925 (hide)

Owner Five Prime Therapeutics, Inc.

Inventors Zhang, Hongbing; Hestir, Kevin; Williams, Lewis T.; Bosch, Elizabeth; Lee, Ernestine; Wu, Ge; Doberstein, Stephen; Hollenbaugh, Diane; Qin, Minmin; Sadra, Ali; Wong, Justin

Agent Pizzeys

Pub. Number AU-A-2011244925

Parent 2006272759

Filing date 2 November 2011

Wipo publication date 24 November 2011

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

17 November 2011 Complete Application Filed

24 November 2011 Application Open to Public Inspection

  Published as AU-A-2011244925

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011244926-Fluid level monitoring system and method

2011244924-A method and system for synchronizing presentation of a dynamic data set to a plurality of nodes